<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03121612</url>
  </required_header>
  <id_info>
    <org_study_id>MTTS-01-2017</org_study_id>
    <nct_id>NCT03121612</nct_id>
  </id_info>
  <brief_title>Comparison of CPAP Machines With Reusable vs Disposable Circuits</brief_title>
  <official_title>Randomised Trial Comparing CPAP Machines With Reusable vs Disposable Circuits</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Technology Transfer and Services Hong Kong Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MS Ramaiah Medical College &amp; Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wellcome Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical Technology Transfer and Services Hong Kong Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess the basic functionality of a newly designed CPAP machine with
      reusable circuits to existing machines with disposable circuits, for treatment of newborn
      infants diagnosed with respiratory distress syndrome. The assessment will compare a
      comprehensive list of physiological parameters over the first 72 hours of treatment, and will
      also monitor rates of side effects and adverse events. The null hypothesis is that infants
      treated on the two categories of machine (reusable vs disposable) will not differ in relation
      to key physiological parameters by more than 0.63 standard deviations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the commonest sources of serious newborn morbidity and mortality is difficulty with
      breathing. When this occurs, three main types of supportive therapy are available to increase
      the provision of oxygen to cells: a) passive provision of oxygen-enriched gases (i.e., higher
      than the 21% O2 found in the earth's atmosphere) through tubes in the nostrils, or by putting
      a hood over the baby's head and enriching the gases under that hood; b) provision of room air
      or oxygen-enriched gasses under pressure, frequently performed using a method called
      continuous positive airway pressure [CPAP] therapy; and/or c) by using a machine that is able
      to breath on behalf of the baby, most commonly referred to as mechanical ventilation [MV].

      Passive therapy is the least invasive method but is also of limited benefit, particularly for
      infants born preterm. CPAP is more effective than passive methods because continuous
      distending pressure to the lungs allows better oxygen exchange; however, the distending
      pressure increases the risk of damage to the lung. MV is the only method that can be used on
      babies without a neurological impulse to breath, but the mechanical breathing action can
      damage the lungs, and MV is usually provided through a tube inserted into the lungs which
      increases the risk of lung infection; MV machines are also significantly more expensive than
      CPAP machines.

      In high resource settings, CPAP is now the preferred method of providing oxygen for infants
      where passive therapy is insufficient, because of the lower infection risk, lower risk of
      lung damage, and relative ease of clinical care. CPAP is increasingly recommended for low
      resource settings, but the CPAP machines used in high resource settings are too expensive for
      low resource settings due to high-priced consumables ($US50-200/baby), and are usually
      unusable in low resource settings because they require 'medical air' (clean air in a
      cylinder, or through a piped wall system) with which to blend 100% oxygen. Low cost
      'indigenous' machines ('jury-rigged' by hospital staff) have also been developed, but these
      do not provide the heated, humidified and blended gasses, that are recommended for CPAP.

      This study seeks to evaluate a novel CPAP machine that provides heated, humidified, blended
      gasses, in line with recommendations for high-resource settings, while massively reducing
      costs by including re-usable tube sets and humidifiers that can be autoclaved, and with an
      on-board air-compressor to allow use in a broader range of clinical settings. By reducing the
      cost per CPAP treatment, such a machine can dramatically increase the number of hospitals in
      low resource settings that can provide high quality CPAP treatment.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    insufficient number of subjects
  </why_stopped>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">October 15, 2018</completion_date>
  <primary_completion_date type="Actual">August 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>As the machines are physically distinct, blinding of participants, care providers and investigators is not feasible. The assessment of most outcomes cannot therefore be blinded, with one exception: x-rays for neonates with suspected pneumothorax will be provided to a radiologist for independent verification; the radiologist will not be in the nursery and will therefore be blinded to treatment allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>FiO2</measure>
    <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement</time_frame>
    <description>Fraction of inspired oxygen (FiO2), measured as a change from baseline as shown on the two machines.
Note. Outcome contaminated. An SpO2 target of 90-95% reflects currently recommended practice for neonates; when SpO2 exceeds the target, FiO2 should be reduced. The majority of readings were at SpO2 &gt; 95%, so FiO2 for these SpO2 readings reflects oxygen provided, not oxygen required to achieve the recommended SpO2 target range (i.e., the FiO2 provided was excessive, by an unknown amount).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement</time_frame>
    <description>Oxygen saturation by pulse oximetry (SpO2), measured as a change from baseline
Note. Outcome contaminated. An SpO2 target of 90-95% reflects currently recommended practice for neonates. The majority of readings were at SpO2 &gt; 95%, above SpO2 target (90-95%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement</time_frame>
    <description>Respiratory rate (breaths/minute), measured as a change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial pH</measure>
    <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement (where available)</time_frame>
    <description>pH measured as a change from baseline (where measured)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial Pressure of Arterial Oxygen (PaO2)</measure>
    <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement (where available)</time_frame>
    <description>PaO2 measured as a change from baseline (where measured)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial Pressure of Arterial Carbon Dioxide (PaCO2)</measure>
    <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement (where available)</time_frame>
    <description>PaCO2 measured as a change from baseline (where measured)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Died or Needed Intubation and/or Mechanical Ventilation, as a Measure of CPAP Failure, Measured to Date and Time of Cessation of CPAP Treatment</measure>
    <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
    <description>Death or need for intubation and mechanical ventilation as demonstrated by an FiO2 requirement ≥ 60% for ≥ 1 hour to maintain SpO2 at 90-95%
Note. An SpO2 target of 90-95% reflects currently recommended practice for neonates. FiO2 and SpO2 at time of intubation and ventilation not separately recorded, so we report this endpoint as recorded by clinicians, assuming that they have verified FiO2 [≥ 60% for ≥ 1 hour] and SpO2 [targeting 90-95%] requirements at the time of intubation and ventilation. If SpO2 was actually &gt;95% (not 90-95%) at the time of intubation and ventilation, then FiO2 would be higher than required to meet the target range, by an unknown amount (possibly not meeting the FiO2 threshold of ≥ 60% for ≥ 1 hour, required to justify intubation and ventilation). We note this potential source of contamination because the results of Outcome #2 show that the majority of SpO2 readings were &gt;95%.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surfactant Provided When FiO2 &gt; 40% to Maintain SpO2 at 90-95% for ≥ 30 Minutes, With Respiratory Distress Syndrome Confirmed by Chest X-Ray</measure>
    <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
    <description>Surfactant provided when FiO2 &gt; 40% to maintain SpO2 at 90-95% for ≥ 30 minutes, with Respiratory Distress Syndrome confirmed by chest X-Ray
Note that endpoint likely corrupted because SpO2 was not routinely targeting 90-95%, and large number of infants received surfactant before achieving &gt;40% or without having x-ray confirmation of RDS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP Failure or Surfactant Provision</measure>
    <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
    <description>Outcomes 6 or 7
Note that endpoint likely corrupted because SpO2 was not routinely targeting 90-95%, and large number of infants received surfactant before achieving &gt;40% or without having x-ray confirmation of RDS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP Duration</measure>
    <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
    <description>Duration of CPAP treatment (hours) in infants that do not fail CPAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious Adverse Event</measure>
    <time_frame>From date and time of birth to date and time of hospital discharge, assessed to a maximum of 2 months of age.</time_frame>
    <description>A Serious adverse Event (SAEs) is any untoward medial occurrence that:
Results in death;
Is life-threatening; [NOTE: the term &quot;life-threatening&quot; in the definition of &quot;serious&quot; refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.]
Requires inpatient hospitalisation or prolongation of existing hospitalisation;
Results in persistent or significant disability/incapacity, or
Is a congenital anomaly/birth defect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #1</measure>
    <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
    <description>Damage to the nasal septum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #2</measure>
    <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
    <description>Damage to the nares of the infant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #3</measure>
    <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
    <description>Pneumothorax as diagnosed by X-ray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #4</measure>
    <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
    <description>Intra-ventricular haemorrhage (IVH), intra-cranial haemorrhage (ICH), or periventricular leukomalacia (PVL) as diagnosed by cranial ultrasound scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #5</measure>
    <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
    <description>FiO2 ≥ 60% to maintain SpO2 at 90-95% for one hour or more, during CPAP treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #6</measure>
    <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
    <description>Intubation and mechanical ventilation
Note. An SpO2 target of 90-95% reflects currently recommended practice for neonates. FiO2 and SpO2 at time of intubation and ventilation not separately recorded, so we report this endpoint as recorded by clinicians, assuming that they have verified FiO2 [≥ 60% for ≥ 1 hour] and SpO2 [targeting 90-95%] requirements at the time of intubation and ventilation. If SpO2 was actually &gt;95% (not 90-95%) at the time of intubation and ventilation, then FiO2 would be higher than required to meet the target range, by an unknown amount (possibly not meeting the FiO2 threshold of ≥ 60% for ≥ 1 hour, required to justify intubation and ventilation). We note this potential source of contamination because the results of Outcome #2 show that the majority of SpO2 readings were &gt;95%.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #7</measure>
    <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
    <description>For infants born at 28+0 to 33+6 weeks' gestation, oxygen dependent at 36 weeks' gestation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sentinel Outcome #8</measure>
    <time_frame>From date and time of randomization to date and time of hospital discharge, assessed to a maximum of 2 months of age.</time_frame>
    <description>Death of the infant before hospitals discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <arm_group>
    <arm_group_label>Dolphin CPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fisher-Paykel CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>CPAP therapy</description>
    <arm_group_label>Dolphin CPAP</arm_group_label>
    <arm_group_label>Fisher-Paykel CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Infants born at Ramaiah Medical College hospital ('inborn infants');

          2. Infants born elsewhere, and admitted to Ramaiah Medical College hospital under 6 hours
             of age (&quot;outborn infants&quot;);

          3. Infants with a gestational age at birth (weeks +days) in the range ≥ 28+0 to ≤ 36+6;

          4. Infants thought to have RDS (clinically diagnosed after onset of respiratory distress
             &lt;6 hours of age, sometimes confirmed by X-ray showing homogenous bilateral opacity)
             who would routinely be provided CPAP therapy; and

          5. Infants &lt;24 hours old at the time of fulfilling other inclusion criteria.

        Exclusion Criteria:

          1. Infants with a 1-minute Apgar score &lt;3 (as a marker of severe birth asphyxia);

          2. Infants who received MV prior to randomisation;

          3. Infants with suspected meconium aspiration syndrome will be excluded to avoid any
             imbalance in this condition across groups;

          4. Infants clinically suspected to have another specified serious condition as their main
             disease process, diagnosed prior to randomisation, specifically: cardiac anomaly,
             other congenital malformation with respiratory sequelae, septicaemia, pulmonary
             haemorrhage, pneumothorax, meningitis, poor respiratory effort or recurrent apnoea, or
             brain haemorrhage (IVH Grades III or IV);

          5. Infants who have an airway abnormality precluding the use of the standard CPAP
             interface proposed for this study (e.g., Pierre-Robin sequence, cleft lip or cleft
             palate) or who have a neuromuscular condition that interferes with respiration;

          6. Any infant whose treating clinician believes should not be randomised due to some
             other condition, or for any other reason (reason to be documented).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>G CM Pradeep, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MS Ramaiah Medical College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M.S. Ramaiah Medical College</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560054</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>February 12, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2017</study_first_posted>
  <results_first_submitted>September 8, 2019</results_first_submitted>
  <results_first_submitted_qc>October 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 4, 2019</results_first_posted>
  <last_update_submitted>November 18, 2019</last_update_submitted>
  <last_update_submitted_qc>November 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>MS Ramaiah Medical College &amp; Hospitals</investigator_affiliation>
    <investigator_full_name>Dr. Pradeep GCM</investigator_full_name>
    <investigator_title>Neonatal Intensive Care Unit</investigator_title>
  </responsible_party>
  <keyword>RDS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 31, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT03121612/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 3, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT03121612/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>There were no wash-out or run-in procedures. No enrolled participant was excluded from the study before randomisation.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Dolphin Continuous Positive Airway Pressure</title>
          <description>Continuous Positive Airway Pressure (CPAP) machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
        </group>
        <group group_id="P2">
          <title>Fisher-Paykel Continuous Positive Airway Pressure</title>
          <description>Fisher-Paykel (F&amp;P) Continuous Positive Airway Pressure (CPAP) machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dolphin Continuous Positive Airway Pressure</title>
          <description>Continuous Positive Airway Pressure (CPAP) machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
        </group>
        <group group_id="B2">
          <title>Fisher-Paykel Continuous Positive Airway Pressure</title>
          <description>Fisher-Paykel (F&amp;P) Continuous Positive Airway Pressure (CPAP) machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>Gestational age</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.86" lower_limit="31.29" upper_limit="32.71"/>
                    <measurement group_id="B2" value="31.57" lower_limit="30.14" upper_limit="32.86"/>
                    <measurement group_id="B3" value="31.71" lower_limit="30.57" upper_limit="32.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>India</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Birthweight</title>
          <units>Grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1409" spread="311"/>
                    <measurement group_id="B2" value="1434" spread="417"/>
                    <measurement group_id="B3" value="1421" spread="363"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>FiO2 at baseline</title>
          <units>Percentage of inspired oxygen</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40" lower_limit="40" upper_limit="50"/>
                    <measurement group_id="B2" value="40" lower_limit="40" upper_limit="50"/>
                    <measurement group_id="B3" value="40" lower_limit="40" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>SpO2 at baseline</title>
          <units>Percentage capillary oxygen saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96" lower_limit="95" upper_limit="98"/>
                    <measurement group_id="B2" value="97" lower_limit="94" upper_limit="98"/>
                    <measurement group_id="B3" value="97" lower_limit="94" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Respiratory rate at baseline</title>
          <units>Breaths/minute</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="26"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.5" lower_limit="40" upper_limit="44"/>
                    <measurement group_id="B2" value="43" lower_limit="40" upper_limit="46"/>
                    <measurement group_id="B3" value="43" lower_limit="40" upper_limit="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>pH at baseline</title>
          <population>Only 31/51 infants had a blood gas at baseline</population>
          <units>pH</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.29" lower_limit="7.22" upper_limit="7.35"/>
                    <measurement group_id="B2" value="7.34" lower_limit="7.28" upper_limit="7.38"/>
                    <measurement group_id="B3" value="7.29" lower_limit="7.23" upper_limit="7.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Partial pressure of arterial oxygen at baseline</title>
          <population>Only 31/51 infants had a blood gas at baseline</population>
          <units>Torr</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="115" lower_limit="74" upper_limit="140"/>
                    <measurement group_id="B2" value="139" lower_limit="50" upper_limit="176"/>
                    <measurement group_id="B3" value="115" lower_limit="65" upper_limit="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Partial pressure of arterial carbon dioxide at baseline</title>
          <population>Only 31/51 infants had a blood gas at baseline</population>
          <units>Torr</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="19"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.9" lower_limit="27.8" upper_limit="45.9"/>
                    <measurement group_id="B2" value="27.5" lower_limit="23.4" upper_limit="40.4"/>
                    <measurement group_id="B3" value="37.2" lower_limit="24.9" upper_limit="44.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>FiO2</title>
        <description>Fraction of inspired oxygen (FiO2), measured as a change from baseline as shown on the two machines.
Note. Outcome contaminated. An SpO2 target of 90-95% reflects currently recommended practice for neonates; when SpO2 exceeds the target, FiO2 should be reduced. The majority of readings were at SpO2 &gt; 95%, so FiO2 for these SpO2 readings reflects oxygen provided, not oxygen required to achieve the recommended SpO2 target range (i.e., the FiO2 provided was excessive, by an unknown amount).</description>
        <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement</time_frame>
        <population>Number missing at each time point:
6 hrs: 1 Dolphin (failed), 0 FP
12 hrs: 1 Dolphin (failed), 1 FP (recovered)
24 hrs: 6 Dolphin (2 failed + 4 recovered), 4 FP (all recovered)
48 hrs: 16 Dolphin (3 failed + 13 recovered), 11 FP (1 failed + 10 recovered)
72 hrs: 21 Dolphin (3 failed + 18 recovered), 21 FP (1 failed + 20 recovered)</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>FiO2</title>
          <description>Fraction of inspired oxygen (FiO2), measured as a change from baseline as shown on the two machines.
Note. Outcome contaminated. An SpO2 target of 90-95% reflects currently recommended practice for neonates; when SpO2 exceeds the target, FiO2 should be reduced. The majority of readings were at SpO2 &gt; 95%, so FiO2 for these SpO2 readings reflects oxygen provided, not oxygen required to achieve the recommended SpO2 target range (i.e., the FiO2 provided was excessive, by an unknown amount).</description>
          <population>Number missing at each time point:
6 hrs: 1 Dolphin (failed), 0 FP
12 hrs: 1 Dolphin (failed), 1 FP (recovered)
24 hrs: 6 Dolphin (2 failed + 4 recovered), 4 FP (all recovered)
48 hrs: 16 Dolphin (3 failed + 13 recovered), 11 FP (1 failed + 10 recovered)
72 hrs: 21 Dolphin (3 failed + 18 recovered), 21 FP (1 failed + 20 recovered)</population>
          <units>Percentage of inspired oxygen</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 6 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-7" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-10" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="-17" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10" lower_limit="-17" upper_limit="0"/>
                    <measurement group_id="O2" value="-15" lower_limit="-20" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 48 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.5" lower_limit="-20" upper_limit="-10"/>
                    <measurement group_id="O2" value="-12.5" lower_limit="-20" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 72 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10" lower_limit="-19" upper_limit="-5"/>
                    <measurement group_id="O2" value="-7.5" lower_limit="-14.5" upper_limit="-2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis restricted to change at 6 hours, as least affected by missing data.
Distribution non-normal, so non-parametric test (Wilcoxon) used.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Power calculated based on 40 infants in each arm, permitting detection of a difference of 0.67 SD between the groups with power of 80% and alpha=0.05. Study recruitment was below anticipated (51/80) despite extending the planned period of recruitment.</non_inferiority_desc>
            <p_value>0.65</p_value>
            <p_value_desc>Threshold for superiority p&lt;0.05; primary outcome, so not adjusted for multiple comparisons.</p_value_desc>
            <method>van Elteren's extension to Wilcoxon</method>
            <method_desc>van Elteren's extension used to control for stratification by gestation</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Planned sub-group analysis for infants born at 28-33 gestational weeks (n=41). No adjustment for multiple comparisons.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.64</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Planned sub-group analysis for infants born at 34-36 gestational weeks (n=10). No adjustment for multiple comparisons.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.0</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SpO2</title>
        <description>Oxygen saturation by pulse oximetry (SpO2), measured as a change from baseline
Note. Outcome contaminated. An SpO2 target of 90-95% reflects currently recommended practice for neonates. The majority of readings were at SpO2 &gt; 95%, above SpO2 target (90-95%).</description>
        <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement</time_frame>
        <population>Number missing:
6 hrs: 1 Dolphin (failed), 0 FP
12 hrs: 1 Dolphin (failed), 1 FP (recovered)
24 hrs: 6 Dolphin (2 failed + 4 recovered), 4 FP (all recovered)
48 hrs: 16 Dolphin (3 failed + 13 recovered), 11 FP (1 failed + 10 recovered)
72 hrs: 21 Dolphin (3 failed + 18 recovered), 21 FP (1 failed + 20 recovered)</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>SpO2</title>
          <description>Oxygen saturation by pulse oximetry (SpO2), measured as a change from baseline
Note. Outcome contaminated. An SpO2 target of 90-95% reflects currently recommended practice for neonates. The majority of readings were at SpO2 &gt; 95%, above SpO2 target (90-95%).</description>
          <population>Number missing:
6 hrs: 1 Dolphin (failed), 0 FP
12 hrs: 1 Dolphin (failed), 1 FP (recovered)
24 hrs: 6 Dolphin (2 failed + 4 recovered), 4 FP (all recovered)
48 hrs: 16 Dolphin (3 failed + 13 recovered), 11 FP (1 failed + 10 recovered)
72 hrs: 21 Dolphin (3 failed + 18 recovered), 21 FP (1 failed + 20 recovered)</population>
          <units>Percentage capillary oxygen saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 6 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="-0.5" upper_limit="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="-1" upper_limit="2.5"/>
                    <measurement group_id="O2" value="0" lower_limit="-2" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 48 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="-4" upper_limit="1"/>
                    <measurement group_id="O2" value="-0.5" lower_limit="-2" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 72 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" lower_limit="-5" upper_limit="4"/>
                    <measurement group_id="O2" value="-0.5" lower_limit="-1" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis restricted to change at 6 hours, as least affected by missing data.
Distribution not normal by visual examination, so non-parametric test (Wilcoxon) used.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Power calculated based on 40 infants in each arm, permitting detection of a difference of 0.67 SD between the groups with power of 80% and alpha=0.05. Study recruitment was below anticipated (51/80) despite extending the planned period of recruitment.</non_inferiority_desc>
            <p_value>0.80</p_value>
            <p_value_desc>Threshold for superiority p&lt;0.05; not adjusted for multiple comparisons</p_value_desc>
            <method>van Elteren's extension to Wilcoxon</method>
            <method_desc>van Elteren's extension used to control for stratification by gestation.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Rate</title>
        <description>Respiratory rate (breaths/minute), measured as a change from baseline</description>
        <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement</time_frame>
        <population>Number missing (and thus imputed):
6 hrs: 1 Dolphin (failed), 0 FP
12 hrs: 1 Dolphin (failed), 1 FP (recovered)
24 hrs: 6 Dolphin (2 failed + 4 recovered), 4 FP (all recovered)
48 hrs: 16 Dolphin (3 failed + 13 recovered), 11 FP (1 failed + 10 recovered)
72 hrs: 21 Dolphin (3 failed + 18 recovered), 21 FP (1 failed + 20 recovered)</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Rate</title>
          <description>Respiratory rate (breaths/minute), measured as a change from baseline</description>
          <population>Number missing (and thus imputed):
6 hrs: 1 Dolphin (failed), 0 FP
12 hrs: 1 Dolphin (failed), 1 FP (recovered)
24 hrs: 6 Dolphin (2 failed + 4 recovered), 4 FP (all recovered)
48 hrs: 16 Dolphin (3 failed + 13 recovered), 11 FP (1 failed + 10 recovered)
72 hrs: 21 Dolphin (3 failed + 18 recovered), 21 FP (1 failed + 20 recovered)</population>
          <units>Breaths per minute</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 6 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="25"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" lower_limit="-2" upper_limit="3"/>
                    <measurement group_id="O2" value="0" lower_limit="-2" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-2" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="-2" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" lower_limit="-4" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="-2" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 48 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" lower_limit="-4" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="-2" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 72 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="-2" upper_limit="4"/>
                    <measurement group_id="O2" value="0" lower_limit="-1" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis restricted to change at 6 hours, as least affected by missing data.
Distribution non-normal, so non-parametric test (Wilcoxon) used.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Power calculated based on 40 infants in each arm, permitting detection of a difference of 0.67 SD between the groups with power of 80% and alpha=0.05. Study recruitment was below anticipated (51/80) despite extending the planned period of recruitment.</non_inferiority_desc>
            <p_value>0.86</p_value>
            <p_value_desc>Threshold for superiority p&lt;0.05; not adjusted for multiple comparisons.</p_value_desc>
            <method>van Elteren's extension to Wilcoxon</method>
            <method_desc>van Elteren's extension used to control for stratification by gestation.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Arterial pH</title>
        <description>pH measured as a change from baseline (where measured)</description>
        <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement (where available)</time_frame>
        <population>Only 31/51 infants had a baseline blood gas taken, and only 7 of these had a second or subsequent test, with five of them at 6 hours, two each at 12 and 24 hours and one each at 48 and 72 hours. No statistical testing performed.</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Arterial pH</title>
          <description>pH measured as a change from baseline (where measured)</description>
          <population>Only 31/51 infants had a baseline blood gas taken, and only 7 of these had a second or subsequent test, with five of them at 6 hours, two each at 12 and 24 hours and one each at 48 and 72 hours. No statistical testing performed.</population>
          <units>pH</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 6 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.135" lower_limit="0.08" upper_limit="0.19"/>
                    <measurement group_id="O2" value="0.05" lower_limit="0.00" upper_limit="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" lower_limit="0.19" upper_limit="0.19"/>
                    <measurement group_id="O2" value="0.23" lower_limit="0.23" upper_limit="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.015" lower_limit="0.0" upper_limit="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 48 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="0.01" lower_limit="0.01" upper_limit="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 72 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="-0.01" lower_limit="-0.01" upper_limit="-0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Partial Pressure of Arterial Oxygen (PaO2)</title>
        <description>PaO2 measured as a change from baseline (where measured)</description>
        <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement (where available)</time_frame>
        <population>Only 31/51 infants had a baseline blood gas taken, and only 7 of these had a second or subsequent test, with five of them at 6 hours, two each at 12 and 24 hours and one each at 48 and 72 hours. No statistical testing performed.</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin Continuous Positive Airway Pressure</title>
            <description>Continuous Positive Airway Pressure (CPAP) machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel Continuous Positive Airway Pressure</title>
            <description>Fisher-Paykel (F&amp;P) Continuous Positive Airway Pressure (CPAP) machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Partial Pressure of Arterial Oxygen (PaO2)</title>
          <description>PaO2 measured as a change from baseline (where measured)</description>
          <population>Only 31/51 infants had a baseline blood gas taken, and only 7 of these had a second or subsequent test, with five of them at 6 hours, two each at 12 and 24 hours and one each at 48 and 72 hours. No statistical testing performed.</population>
          <units>Torr</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 6 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-138" lower_limit="-179" upper_limit="-97"/>
                    <measurement group_id="O2" value="-47" lower_limit="-67" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-60.2" lower_limit="-60.2" upper_limit="-60.2"/>
                    <measurement group_id="O2" value="12.1" lower_limit="12.1" upper_limit="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-42.5" lower_limit="-85" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 48 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="-9.3" lower_limit="-9.3" upper_limit="-9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 72 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="15.6" lower_limit="15.6" upper_limit="15.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Partial Pressure of Arterial Carbon Dioxide (PaCO2)</title>
        <description>PaCO2 measured as a change from baseline (where measured)</description>
        <time_frame>6, 12, 24, 48 and 72 hours after treatment commencement (where available)</time_frame>
        <population>Only 31/51 infants had a baseline blood gas taken, and only 7 of these had a second or subsequent test, with five of them at 6 hours, two each at 12 and 24 hours and one each at 48 and 72 hours. No statistical testing performed.</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin Continuous Positive Airway Pressure</title>
            <description>Continuous Positive Airway Pressure (CPAP) machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel Continuous Positive Airway Pressure</title>
            <description>Fisher-Paykel (F&amp;P) Continuous Positive Airway Pressure (CPAP) machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Partial Pressure of Arterial Carbon Dioxide (PaCO2)</title>
          <description>PaCO2 measured as a change from baseline (where measured)</description>
          <population>Only 31/51 infants had a baseline blood gas taken, and only 7 of these had a second or subsequent test, with five of them at 6 hours, two each at 12 and 24 hours and one each at 48 and 72 hours. No statistical testing performed.</population>
          <units>Torr</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 6 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-17" lower_limit="-27" upper_limit="-7"/>
                    <measurement group_id="O2" value="-9" lower_limit="-30" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 12 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18.6" lower_limit="-18.6" upper_limit="-18.6"/>
                    <measurement group_id="O2" value="-5.9" lower_limit="-5.9" upper_limit="-5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 24 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12" lower_limit="-24" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 48 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="-0.1" lower_limit="-0.1" upper_limit="-0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 72 hours</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="6.4" lower_limit="6.4" upper_limit="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Died or Needed Intubation and/or Mechanical Ventilation, as a Measure of CPAP Failure, Measured to Date and Time of Cessation of CPAP Treatment</title>
        <description>Death or need for intubation and mechanical ventilation as demonstrated by an FiO2 requirement ≥ 60% for ≥ 1 hour to maintain SpO2 at 90-95%
Note. An SpO2 target of 90-95% reflects currently recommended practice for neonates. FiO2 and SpO2 at time of intubation and ventilation not separately recorded, so we report this endpoint as recorded by clinicians, assuming that they have verified FiO2 [≥ 60% for ≥ 1 hour] and SpO2 [targeting 90-95%] requirements at the time of intubation and ventilation. If SpO2 was actually &gt;95% (not 90-95%) at the time of intubation and ventilation, then FiO2 would be higher than required to meet the target range, by an unknown amount (possibly not meeting the FiO2 threshold of ≥ 60% for ≥ 1 hour, required to justify intubation and ventilation). We note this potential source of contamination because the results of Outcome #2 show that the majority of SpO2 readings were &gt;95%.</description>
        <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Died or Needed Intubation and/or Mechanical Ventilation, as a Measure of CPAP Failure, Measured to Date and Time of Cessation of CPAP Treatment</title>
          <description>Death or need for intubation and mechanical ventilation as demonstrated by an FiO2 requirement ≥ 60% for ≥ 1 hour to maintain SpO2 at 90-95%
Note. An SpO2 target of 90-95% reflects currently recommended practice for neonates. FiO2 and SpO2 at time of intubation and ventilation not separately recorded, so we report this endpoint as recorded by clinicians, assuming that they have verified FiO2 [≥ 60% for ≥ 1 hour] and SpO2 [targeting 90-95%] requirements at the time of intubation and ventilation. If SpO2 was actually &gt;95% (not 90-95%) at the time of intubation and ventilation, then FiO2 would be higher than required to meet the target range, by an unknown amount (possibly not meeting the FiO2 threshold of ≥ 60% for ≥ 1 hour, required to justify intubation and ventilation). We note this potential source of contamination because the results of Outcome #2 show that the majority of SpO2 readings were &gt;95%.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.0</p_value>
            <p_value_desc>Not adjusted for multiple comparisons.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>No failures in older stratum, so stratification by gestational age-group not controlled for in analysis.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surfactant Provided When FiO2 &gt; 40% to Maintain SpO2 at 90-95% for ≥ 30 Minutes, With Respiratory Distress Syndrome Confirmed by Chest X-Ray</title>
        <description>Surfactant provided when FiO2 &gt; 40% to maintain SpO2 at 90-95% for ≥ 30 minutes, with Respiratory Distress Syndrome confirmed by chest X-Ray
Note that endpoint likely corrupted because SpO2 was not routinely targeting 90-95%, and large number of infants received surfactant before achieving &gt;40% or without having x-ray confirmation of RDS.</description>
        <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Surfactant Provided When FiO2 &gt; 40% to Maintain SpO2 at 90-95% for ≥ 30 Minutes, With Respiratory Distress Syndrome Confirmed by Chest X-Ray</title>
          <description>Surfactant provided when FiO2 &gt; 40% to maintain SpO2 at 90-95% for ≥ 30 minutes, with Respiratory Distress Syndrome confirmed by chest X-Ray
Note that endpoint likely corrupted because SpO2 was not routinely targeting 90-95%, and large number of infants received surfactant before achieving &gt;40% or without having x-ray confirmation of RDS.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.33</p_value>
            <p_value_desc>Not adjusted for multiple comparisons</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
            <method_desc>Controlling for stratification by gestational group.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CPAP Failure or Surfactant Provision</title>
        <description>Outcomes 6 or 7
Note that endpoint likely corrupted because SpO2 was not routinely targeting 90-95%, and large number of infants received surfactant before achieving &gt;40% or without having x-ray confirmation of RDS.</description>
        <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>CPAP Failure or Surfactant Provision</title>
          <description>Outcomes 6 or 7
Note that endpoint likely corrupted because SpO2 was not routinely targeting 90-95%, and large number of infants received surfactant before achieving &gt;40% or without having x-ray confirmation of RDS.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.31</p_value>
            <p_value_desc>Not adjusted for multiple comparisons</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
            <method_desc>Controlling for stratification by gestational age-group.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CPAP Duration</title>
        <description>Duration of CPAP treatment (hours) in infants that do not fail CPAP</description>
        <time_frame>From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.</time_frame>
        <population>Excludes 3 Dolphin and 2 FP randomised infants that failed treatment (escalated to mechanical ventilation)</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>CPAP Duration</title>
          <description>Duration of CPAP treatment (hours) in infants that do not fail CPAP</description>
          <population>Excludes 3 Dolphin and 2 FP randomised infants that failed treatment (escalated to mechanical ventilation)</population>
          <units>Hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.9" lower_limit="42.1" upper_limit="70.0"/>
                    <measurement group_id="O2" value="56.5" lower_limit="38.0" upper_limit="65.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.81</p_value>
            <p_value_desc>Not adjusted for multiple comparisons.</p_value_desc>
            <method>van Elteren's extension to Wilcoxon</method>
            <method_desc>van Elteren's extension used to control for stratification by gestation</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serious Adverse Event</title>
        <description>A Serious adverse Event (SAEs) is any untoward medial occurrence that:
Results in death;
Is life-threatening; [NOTE: the term &quot;life-threatening&quot; in the definition of &quot;serious&quot; refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.]
Requires inpatient hospitalisation or prolongation of existing hospitalisation;
Results in persistent or significant disability/incapacity, or
Is a congenital anomaly/birth defect</description>
        <time_frame>From date and time of birth to date and time of hospital discharge, assessed to a maximum of 2 months of age.</time_frame>
        <population>The infant that died recovered after CPAP but was subsequently treated for apnea and a patent ductus arteriosus. Twelve days after CPAP cessation the infant commenced antibiotics for elevated CRP and was intubated and ventilated and died. The Data Safety Monitoring Committee determined that the death was unrelated to treatment group.</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Serious Adverse Event</title>
          <description>A Serious adverse Event (SAEs) is any untoward medial occurrence that:
Results in death;
Is life-threatening; [NOTE: the term &quot;life-threatening&quot; in the definition of &quot;serious&quot; refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.]
Requires inpatient hospitalisation or prolongation of existing hospitalisation;
Results in persistent or significant disability/incapacity, or
Is a congenital anomaly/birth defect</description>
          <population>The infant that died recovered after CPAP but was subsequently treated for apnea and a patent ductus arteriosus. Twelve days after CPAP cessation the infant commenced antibiotics for elevated CRP and was intubated and ventilated and died. The Data Safety Monitoring Committee determined that the death was unrelated to treatment group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.0</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #1</title>
        <description>Damage to the nasal septum</description>
        <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #1</title>
          <description>Damage to the nasal septum</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #2</title>
        <description>Damage to the nares of the infant</description>
        <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #2</title>
          <description>Damage to the nares of the infant</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #3</title>
        <description>Pneumothorax as diagnosed by X-ray</description>
        <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #3</title>
          <description>Pneumothorax as diagnosed by X-ray</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #4</title>
        <description>Intra-ventricular haemorrhage (IVH), intra-cranial haemorrhage (ICH), or periventricular leukomalacia (PVL) as diagnosed by cranial ultrasound scan</description>
        <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #4</title>
          <description>Intra-ventricular haemorrhage (IVH), intra-cranial haemorrhage (ICH), or periventricular leukomalacia (PVL) as diagnosed by cranial ultrasound scan</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #5</title>
        <description>FiO2 ≥ 60% to maintain SpO2 at 90-95% for one hour or more, during CPAP treatment</description>
        <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #5</title>
          <description>FiO2 ≥ 60% to maintain SpO2 at 90-95% for one hour or more, during CPAP treatment</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #6</title>
        <description>Intubation and mechanical ventilation
Note. An SpO2 target of 90-95% reflects currently recommended practice for neonates. FiO2 and SpO2 at time of intubation and ventilation not separately recorded, so we report this endpoint as recorded by clinicians, assuming that they have verified FiO2 [≥ 60% for ≥ 1 hour] and SpO2 [targeting 90-95%] requirements at the time of intubation and ventilation. If SpO2 was actually &gt;95% (not 90-95%) at the time of intubation and ventilation, then FiO2 would be higher than required to meet the target range, by an unknown amount (possibly not meeting the FiO2 threshold of ≥ 60% for ≥ 1 hour, required to justify intubation and ventilation). We note this potential source of contamination because the results of Outcome #2 show that the majority of SpO2 readings were &gt;95%.</description>
        <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #6</title>
          <description>Intubation and mechanical ventilation
Note. An SpO2 target of 90-95% reflects currently recommended practice for neonates. FiO2 and SpO2 at time of intubation and ventilation not separately recorded, so we report this endpoint as recorded by clinicians, assuming that they have verified FiO2 [≥ 60% for ≥ 1 hour] and SpO2 [targeting 90-95%] requirements at the time of intubation and ventilation. If SpO2 was actually &gt;95% (not 90-95%) at the time of intubation and ventilation, then FiO2 would be higher than required to meet the target range, by an unknown amount (possibly not meeting the FiO2 threshold of ≥ 60% for ≥ 1 hour, required to justify intubation and ventilation). We note this potential source of contamination because the results of Outcome #2 show that the majority of SpO2 readings were &gt;95%.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.0</p_value>
            <p_value_desc>No adjustment for multiple comparisons.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>No failures in older stratum, so stratification by gestational age-group not controlled for in analysis.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #7</title>
        <description>For infants born at 28+0 to 33+6 weeks' gestation, oxygen dependent at 36 weeks' gestation</description>
        <time_frame>From date and time of randomization to date and time of CPAP cessation, assessed to a maximum of 2 months of age.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #7</title>
          <description>For infants born at 28+0 to 33+6 weeks' gestation, oxygen dependent at 36 weeks' gestation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sentinel Outcome #8</title>
        <description>Death of the infant before hospitals discharge</description>
        <time_frame>From date and time of randomization to date and time of hospital discharge, assessed to a maximum of 2 months of age.</time_frame>
        <population>The infant that died recovered after CPAP but was subsequently treated for apnoeas and a patent ductus arteriosus. Twelve days after CPAP cessation the infant commenced antibiotics for elevated CRP and was intubated and ventilated and died. The Data Safety Monitoring Committee determined that the death was unrelated to treatment group.</population>
        <group_list>
          <group group_id="O1">
            <title>Dolphin CPAP</title>
            <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
          </group>
          <group group_id="O2">
            <title>Fisher-Paykel CPAP</title>
            <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Sentinel Outcome #8</title>
          <description>Death of the infant before hospitals discharge</description>
          <population>The infant that died recovered after CPAP but was subsequently treated for apnoeas and a patent ductus arteriosus. Twelve days after CPAP cessation the infant commenced antibiotics for elevated CRP and was intubated and ventilated and died. The Data Safety Monitoring Committee determined that the death was unrelated to treatment group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.0</p_value>
            <method>Fisher Exact</method>
            <method_desc>No adjustment for multiple comparisons</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected till hospital discharge or two months of age, whichever is earlier.</time_frame>
      <desc>One serious adverse events was monitored, death.</desc>
      <group_list>
        <group group_id="E1">
          <title>Dolphin CPAP</title>
          <description>CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel nasal mask. [Also includes built-in Massimo pulse oximeter, though this is not used for this study, to prevent differential measurement error in SpO2 measurement]
CPAP: CPAP therapy</description>
        </group>
        <group group_id="E2">
          <title>Fisher-Paykel CPAP</title>
          <description>Fisher-Paykel (F&amp;P) CPAP machine with separate oxygen and medical air intakes, with third-party FP-compliant blender, and F&amp;P blender, delivering heated humidified blended gases through a Fisher-Paykel nasal mask.
CPAP: CPAP therapy</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>As required by the governing ethics committee, death for any reason before hospital discharge was defined as a serious adverse event. Details of the death are reported at Outcome #19.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Culture confirmed infection</sub_title>
                <description>Diagnosed with Klebsiella Pneumoniae</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Intubation &amp; Mechanical Ventilation</sub_title>
                <description>Intubation and mechanical ventilation after FiO2&gt;=60%</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="26"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Sample size achieved (n=51) was fewer than than planned (n=80).
Many of the outcomes were affected by a failure to target SpO2 of 90-95% as anticipated in the protocol.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Gaston Arnolda</name_or_title>
      <organization>Arnolda Consulting</organization>
      <phone>+61 2 8068 4963</phone>
      <email>gaston.arnolda@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

